• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估影响少数群体参与临床试验的多种因素:临床试验参与障碍调查的开发

Assessing Multiple Factors Affecting Minority Participation in Clinical Trials: Development of the Clinical Trials Participation Barriers Survey.

作者信息

Allison Karen, Patel Deepkumar, Kaur Ramandeep

机构信息

Department of Ophthalmology, Mount Sinai Hospital, New York, USA.

Public Health, New York Medical College, School of Health Science and Practice, Valhalla, USA.

出版信息

Cureus. 2022 Apr 23;14(4):e24424. doi: 10.7759/cureus.24424. eCollection 2022 Apr.

DOI:10.7759/cureus.24424
PMID:35637812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9127181/
Abstract

The purpose of this review is to analyze factors that influence individuals' decisions to participate in clinical trials focusing on racial and ethnic disparities that exist in clinical trials. These factors are then used to develop a survey that may be used in a clinical setting to further understand specific factors affecting participation. A comprehensive search of electronic databases was carried out for publications from 2010 to 2021 using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. After reviewing the data, the predominant factors that were encountered in the search were then commented upon and reviewed to create an evidence-based questionnaire. ​​​​Using the comprehensive search, factors that affect clinical trial participation were identified. These factors were then used to create a comprehensive, evidence-based questionnaire to be implemented in a clinical setting to conduct and analyze the factors impacting participation in clinical trials. ​​​​​​​Understanding the factors that primarily impact an individual's decisions to participate or not participate in a clinical trial allow researchers to implement changes to decrease the hesitancy regarding participation.

摘要

本综述的目的是分析影响个人参与临床试验决策的因素,重点关注临床试验中存在的种族和族裔差异。然后利用这些因素设计一项调查,可在临床环境中使用,以进一步了解影响参与的具体因素。使用系统评价和Meta分析的首选报告项目(PRISMA)指南,对2010年至2021年的电子数据库进行了全面检索。在审查数据后,对检索中遇到的主要因素进行了评论和审查,以创建一份基于证据的问卷。通过全面检索,确定了影响临床试验参与的因素。然后利用这些因素创建一份全面的、基于证据的问卷,在临床环境中实施,以调查和分析影响参与临床试验的因素。了解主要影响个人参与或不参与临床试验决策的因素,有助于研究人员做出改变,以减少对参与的犹豫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/91142224d39c/cureus-0014-00000024424-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/fdfaced24200/cureus-0014-00000024424-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/d20340e5791b/cureus-0014-00000024424-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/95a1074528a8/cureus-0014-00000024424-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/0fe713f87dde/cureus-0014-00000024424-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/91142224d39c/cureus-0014-00000024424-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/fdfaced24200/cureus-0014-00000024424-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/d20340e5791b/cureus-0014-00000024424-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/95a1074528a8/cureus-0014-00000024424-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/0fe713f87dde/cureus-0014-00000024424-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e9/9127181/91142224d39c/cureus-0014-00000024424-i05.jpg

相似文献

1
Assessing Multiple Factors Affecting Minority Participation in Clinical Trials: Development of the Clinical Trials Participation Barriers Survey.评估影响少数群体参与临床试验的多种因素:临床试验参与障碍调查的开发
Cureus. 2022 Apr 23;14(4):e24424. doi: 10.7759/cureus.24424. eCollection 2022 Apr.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.种族和民族在原发性开角型青光眼临床试验中的差异:系统评价和荟萃分析。
JAMA Netw Open. 2021 May 3;4(5):e218348. doi: 10.1001/jamanetworkopen.2021.8348.
4
[Factors Influencing Patient Decisions Regarding Cancer Clinical Trial Participation: A Systematic Review].[影响患者参与癌症临床试验决策的因素:一项系统评价]
Hu Li Za Zhi. 2022 Feb;69(1):83-99. doi: 10.6224/JN.202202_69(1).11.
5
Involving South Asian patients in clinical trials.让南亚患者参与临床试验。
Health Technol Assess. 2004 Oct;8(42):iii, 1-109. doi: 10.3310/hta8420.
6
7
Predictors of Persistent Participation in Youth Sport: A Systematic Review and Meta-Analysis.青少年体育持续参与的预测因素:一项系统综述与荟萃分析。
Front Psychol. 2022 May 27;13:871936. doi: 10.3389/fpsyg.2022.871936. eCollection 2022.
8
9
Racial and ethnic minority patient participation in N-of-1 trials: perspectives of healthcare providers and patients.种族和民族少数群体患者参与 N-of-1 试验:医疗保健提供者和患者的观点。
Per Med. 2021 Jul;18(4):347-359. doi: 10.2217/pme-2020-0166. Epub 2021 May 28.
10
HIV/AIDS: a minority health issue.艾滋病毒/艾滋病:一个少数群体的健康问题。
Med Clin North Am. 2005 Jul;89(4):895-912. doi: 10.1016/j.mcna.2005.03.005.

引用本文的文献

1
The research equity and diversity initiative (READI): Changing the face of clinical research through community outreach and engagement.研究公平与多样性倡议(READI):通过社区外展和参与改变临床研究的面貌。
J Clin Transl Sci. 2025 Jul 7;9(1):e156. doi: 10.1017/cts.2025.10085. eCollection 2025.
2
Bridging Health Disparity Gaps in Alzheimer's Disease among Marginalized Populations: Clinical Proteomics as a Case Study.弥合边缘化人群中阿尔茨海默病的健康差距:以临床蛋白质组学为例
ACS Bio Med Chem Au. 2025 Jul 8;5(4):505-518. doi: 10.1021/acsbiomedchemau.5c00074. eCollection 2025 Aug 20.
3
Motivations and experiences of patients with respiratory disease and their caregivers in a multinational trial of mirtazapine for severe breathlessness: a qualitative study (BETTER-B).

本文引用的文献

1
Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.种族和民族在原发性开角型青光眼临床试验中的差异:系统评价和荟萃分析。
JAMA Netw Open. 2021 May 3;4(5):e218348. doi: 10.1001/jamanetworkopen.2021.8348.
2
Discrimination and Medical Mistrust in a Racially and Ethnically Diverse Sample of California Adults.加利福尼亚州不同种族和民族的成年人样本中的歧视和医疗不信任。
Ann Fam Med. 2021 Jan-Feb;19(1):4-15. doi: 10.1370/afm.2632.
3
"When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.
米氮平治疗严重呼吸困难的多国试验中呼吸系统疾病患者及其照护者的动机和经历:一项定性研究(BETTER-B)
BMC Pulm Med. 2025 Aug 14;25(1):390. doi: 10.1186/s12890-025-03862-z.
4
Improving Ethnic Diversity in Cancer Trials Through Healthcare Interpreter Training.通过医疗口译员培训提高癌症试验中的种族多样性。
Cancer Med. 2025 Aug;14(15):e71071. doi: 10.1002/cam4.71071.
5
A Formative Evaluation of Interventions to Enhance Clinical Trial Diversity Guided by the Socioecological Model.以社会生态模型为指导的增强临床试验多样性干预措施的形成性评估。
Cancers (Basel). 2025 Jul 9;17(14):2282. doi: 10.3390/cancers17142282.
6
A Clinical Research Interaction Scale for Racial and Ethnic Minority Participants.针对种族和少数民族参与者的临床研究互动量表。
JAMA Netw Open. 2025 May 1;8(5):e259481. doi: 10.1001/jamanetworkopen.2025.9481.
7
Barriers and strategies for recruitment of pregnant women in contemporary longitudinal birth cohort studies.当代纵向出生队列研究中招募孕妇的障碍与策略
BMC Med Res Methodol. 2025 Apr 28;25(1):117. doi: 10.1186/s12874-025-02570-w.
8
Duke Research at Pickett: The evolution of a free-standing research site partnering with communities toward health equity advancement.皮克特的杜克研究:一个独立研究站点与社区合作以促进健康公平的发展历程。
J Clin Transl Sci. 2024 Oct 28;9(1):e12. doi: 10.1017/cts.2024.649. eCollection 2025.
9
Measuring Representativeness in Clinical Trials.衡量临床试验中的代表性。
Circulation. 2025 Feb 4;151(5):318-330. doi: 10.1161/CIRCULATIONAHA.124.070299. Epub 2025 Feb 3.
10
Fact or Myth? Black Patients Do Not Want to Participate in Clinical Trials.事实还是误解?黑人患者不想参与临床试验。
Clin Transl Gastroenterol. 2025 Apr 1;16(4):e00826. doi: 10.14309/ctg.0000000000000826.
“被邀请参与时”:关于患者同意参与癌症临床试验的系统评价与荟萃分析
J Natl Cancer Inst. 2021 Mar 1;113(3):244-257. doi: 10.1093/jnci/djaa155.
4
Henrietta Lacks: science must right a historical wrong.海瑞塔·拉克斯:科学必须纠正历史错误。
Nature. 2020 Sep;585(7823):7. doi: 10.1038/d41586-020-02494-z.
5
Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators.患者为什么参与研究?对心理社会障碍和促进因素的系统评价综述
Trials. 2020 Mar 12;21(1):259. doi: 10.1186/s13063-020-4197-3.
6
Cultural Competence and Ethnic Diversity in Healthcare.医疗保健中的文化能力与种族多样性
Plast Reconstr Surg Glob Open. 2019 May 16;7(5):e2219. doi: 10.1097/GOX.0000000000002219. eCollection 2019 May.
7
Global Public Attitudes About Clinical Research and Patient Experiences With Clinical Trials.全球公众对临床研究的态度和患者参与临床试验的体验。
JAMA Netw Open. 2018 Oct 5;1(6):e182969. doi: 10.1001/jamanetworkopen.2018.2969.
8
Increasing Diversity in Clinical Trials: Overcoming Critical Barriers.提高临床试验的多样性:克服关键障碍。
Curr Probl Cardiol. 2019 May;44(5):148-172. doi: 10.1016/j.cpcardiol.2018.11.002. Epub 2018 Nov 9.
9
Corrigendum: Estimation of clinical trial success rates and related parameters.勘误:临床试验成功率及相关参数的估计。
Biostatistics. 2019 Apr 1;20(2):366. doi: 10.1093/biostatistics/kxy072.
10
Survey of Awareness and Perceptions of Canadians on the Benefits and Risks of Clinical Trials.加拿大人对临床试验益处和风险的认知与看法调查
Ther Innov Regul Sci. 2019 Sep;53(5):669-677. doi: 10.1177/2168479018805433. Epub 2018 Oct 29.